Skip to main content

Peer Review reports

From: Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study

Original Submission
31 Jan 2022 Submitted Original manuscript
3 Feb 2022 Author responded Author comments - Sophie Aapkes
Resubmission - Version 2
3 Feb 2022 Submitted Manuscript version 2
6 Feb 2022 Editorially accepted
25 Feb 2022 Article published 10.1186/s12876-022-02142-y

You can find further information about peer review here.

Back to article page